Renaissance Technologies’s Ginkgo Bioworks DNA Stock Holding History

Renaissance Technologies’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.35M	Buy	539,856 +439,400	+437%	+$3.67M	0.01%	1420
2026 Q1	$616K	Buy	+100,456	New	+$836K	﹤0.01%	2514
2025 Q1	–	Sell	-114,654	Closed	-$1.13M	–	3537
2024 Q4	$1.13M	Buy	114,654 +45,200	+65%	+$387K	﹤0.01%	2431
2024 Q3	$566K	Sell	69,454 -89,719	-56%	-$899K	﹤0.01%	2734
2024 Q2	$2.13M	Buy	+159,173	New	+$4.75M	﹤0.01%	1847
2022 Q3	–	Sell	-78,535	Closed	-$7.48M	–	4084
2022 Q2	$7.48M	Buy	78,535 +44,552	+131%	+$5.43M	0.01%	1280
2022 Q1	$5.48M	Buy	+33,983	New	+$6.61M	0.01%	1524

Other funds holding DNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Renaissance Technologies's DNA Position: Q2 2026 in Review

Renaissance Technologies increased its Ginkgo Bioworks (DNA) stake by 437% in Q2 2026, buying an estimated $3.67M and bringing the position to 539,856 shares worth $5.35M. The position accounts for 0.01% of the portfolio, ranked #1420.

Renaissance Technologies first reported a position in DNA in Q1 2022 and has held it in 7 quarters since. The position peaked at $7.48M in Q2 2022. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

Renaissance Technologies held 539,856 shares of Ginkgo Bioworks worth $5.35M as of Q2 2026.
Renaissance Technologies bought 439,400 Ginkgo Bioworks shares in Q2 2026, an estimated $3.67M.
Ginkgo Bioworks made up 0.01% of Renaissance Technologies's portfolio in Q2 2026, its #1420 holding.
Renaissance Technologies first reported a position in Ginkgo Bioworks in Q1 2022 and has held it in 7 quarters since.
Renaissance Technologies's Ginkgo Bioworks position peaked at $7.48M in Q2 2022.
184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.